Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... was defined as initiating anti-fracture therapy (bisphosphonate, raloxifene, nasal calcitonin and teriparatide) after fracture in those previously untreated. Of the 1,273 women ...
2009 NOV 16 ... we evaluated change in pain score and the level of the inflammatory neuropeptide, calcitonin gene-related peptide (CGRP), after transfection of the POMC gene in an adjuvant induced ...
2009 NOV 9 ... C57BL/6 mice, a genetic polymorphism results in differential expression of the peptide, calcitonin gene-related polypeptide (CGRP), explaining a strain difference in thermal pain ...
2009 NOV 23 ... According to a study from the United States, "Calcitonin gene-related peptide (CALCB), amylin, and adrenomedullin (ADM) belong to a unique group ...
2009 NOV 23 ... GFP(+) cells, respectively. Somatostatin was found in a small number of neurons, whereas calcitonin gene-related peptide never co-localized with GFP. Moderate co-expression was found for ...
2009 NOV 9 ... (ABM) are largely unknown. Putative mediators include vasoactive peptides, e. g. calcitonin-gene related peptide (CGRP), vasoactive intestinal peptide (VIP), and endothelin-1 ...
2009 NOV 2 ... According to a study from the United States, "The neuropeptide calcitonin gene-related peptide (CGRP) plays a key role in migraine pathophysiology. In this large ...
2009 NOV 2 ... Immunoreactivity for IL-1RI was examined alone (DAB) and together with calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY), CD31 or CD34 by multiple-labelling ...
2009 NOV 16 ... II (DELT), the alpha(2)AR agonist clonidine (CLON) or their combination to inhibit calcitonin gene-related peptide (CGRP) release from spinal cord slices. We then examined the ...
2009 NOV 9 ... revealed a significant AST-promoted increase of intersecting fibres for 5-HT, TH and calcitonin gene-related peptide containing ascending sensory fibres. For a prolonged time period ...
2009 NOV 9 ... Serial histologic changes were analyzed to detect degenerative changes. Expression of calcitonin gene-related peptide (CGRP), prostaglandin E (PGE), and inducible nitric oxide synthase ...
2009 NOV 16 ... be visualized on the endothelium and smooth muscle and on periarterial fibers containing calcitonin gene-related peptide (CGRP). Arterial contractile responses to ET-1 (0.25-16 nM) were ...
2009 NOV 1 ... involved in nociceptive transmission we evaluated the density of substance P (SP), calcitonin gene-related peptide (CGRP), somatostatin (SS) and (B2)-gamma-aminobutiric acid ...
2009 NOV 1 ... in life sciences. According to recent research from Berlin, Germany, "The release of calcitonin gene-related peptide (CGRP) and sensitization of the trigeminal nerve system are ...
2009 NOV 9 ... comparison of the peaks of processed peptides obtained from a mixture of adrenomedullin, calcitonin, and BSA. Among these components of the mixture, only the C-terminal peptide of BSA ...
2009 NOV 1 ... Inc. (OTCBB: EMIS) announced study results in which twice-daily oral salmon calcitonin using Emisphere's proprietary Eligen® Drug Delivery Technology significantly ...
2009 NOV 23 ... September 30, 2008. Increases for both periods were due to the initiation of our oral calcitonin Phase III clinical trial. Net loss for the three months ended September 30, ...
2009 NOV 2 ... and Tarsa Therapeutics, Inc. announced that Unigene has licensed its Phase III oral calcitonin program to Tarsa, a new company formed by a syndicate of three venture capital funds ...
Subject: Unigene Laboratories, Inc. / Tarsa Therapeutics, Inc.
